A key gene that fuels the molecular cascade driving prostate cancer bone metastasis progression may open avenues for targeted therapies. Laura is an assistant editor for The Scientist. She earned her ...

which reduces pain and fracture risk Improving progression-free survival and overall survival Reducing the risk of bone metastases from breast cancer and possibly prostate cancer by a third ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk ...

New research maps the global burden of male cancers from 1990 to 2040, showing how aging, lifestyle, and healthcare access ...

In mouse models of prostate cancer, MTX-101 delivered twice a week reduced tumor growth, lung metastases, bone remodeling, and tissue loss induced by the presence of metastatic cancer cells in the ...

Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, ...

SAN FRANCISCO -- Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when ...

it is called metastasis. These metastatic cancer cells are the same type of cancer as the primary tumor. For example, if prostate cancer spreads to the bone, the cancer cells in the bone are actually ...

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...